Avai Bio, Inc.
AVAI· OTC
AVAIAvai Bio, Inc.
Filed Aug 23, 2021 · 10-Q · 54 days after period end · 0001740797-21-000023
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Net Income | $396.33K | $48.68K | -$14.70K | -$6.20K |
| EPS Diluted | — | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Avai Bio, Inc. · CIK 1740797 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 23, 2021 · 54 d after period end
